Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Top Publications
Garland, SM, Brown, DR.
Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer.
Expert Opinion on Biological Therapy
14(4)
:
527 -534
2014
view publication
Cornall, AM, Quint, WH, Garland, SM, Tabrizi, SN.
Evaluation of an automated SPF10-LiPA25 assay for detection and typing of human papillomavirus in archival samples.
Journal of Virological Methods
199:
116 -118
2014
view publication
Zou, H, Tabrizi, SN, Grulich, AE, Garland, SM, Hocking, JS, Bradshaw, CS, Morrow, A, Prestage, G, Cornall, AM, Fairley, CK, et al.
Early Acquisition of Anogenital Human Papillomavirus Among Teenage Men Who Have Sex With Men.
The Journal of Infectious Diseases
209(5)
:
642 -651
2014
view publication
Gwee, A, Curtis, N, Connell, TG, Garland, S, Daley, AJ.
Ganciclovir for the Treatment of Congenital Cytomegalovirus.
The Pediatric Infectious Disease Journal
33(1)
:
115
2014
view publication
Liyanage, SS, Segelov, E, Malik, A, Garland, SM, Tabrizi, SN, Cummins, E, Seale, H, Rahman, B, Moa, A, Barbour, AP, et al.
A Case-Control Study of the Role of Human Papillomavirus in Oesophageal Squamous Cell Carcinoma in Australia.
Journal of Oncology
2014:
236482
2014
view publication